Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NYSE | Common Stock
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain.
It operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women's health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada.
This segment offers its products under Burt's Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands.
Consumer Self-Care International segment comprises consumer self-care product categories outside theU. S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe.
In addition, the company offers contract manufacturing services.
Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 24 | 0.29 Decreased by -35.56% | 0.23 Increased by +26.09% |
| Feb 27, 24 | 0.86 Increased by +14.67% | 0.83 Increased by +3.61% |
| Nov 7, 23 | 0.64 Increased by +14.29% | 0.63 Increased by +1.59% |
| Aug 8, 23 | 0.63 Increased by +46.51% | 0.51 Increased by +23.53% |
| May 9, 23 | 0.45 Increased by +36.36% | 0.42 Increased by +7.14% |
| Feb 27, 23 | 0.75 Increased by +25.00% | 0.71 Increased by +5.63% |
| Nov 8, 22 | 0.56 Increased by +24.44% | 0.67 Decreased by -16.42% |
| Aug 9, 22 | 0.43 Decreased by -14.00% | 0.44 Decreased by -2.27% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 1.12 B Increased by +2.15% | 14.20 M Increased by +127.26% | Increased by +1.26% Increased by +126.68% |
| Jun 30, 23 | 1.19 B Increased by +6.37% | 8.40 M Increased by +112.94% | Increased by +0.70% Increased by +112.17% |
| Mar 31, 23 | 1.18 B Increased by +9.98% | -1.10 M Increased by +15.38% | Decreased by -0.09% Increased by +23.06% |
| Dec 31, 22 | 1.16 B Increased by +4.56% | -12.70 M Decreased by -232.29% | Decreased by -1.10% Decreased by -226.52% |
| Sep 30, 22 | 1.10 B Increased by +5.51% | -52.10 M Increased by +11.54% | Decreased by -4.74% Increased by +16.17% |
| Jun 30, 22 | 1.12 B Increased by +14.33% | -64.90 M Decreased by -12.48% | Decreased by -5.79% Increased by +1.62% |
| Mar 31, 22 | 1.07 B Increased by +6.39% | -1.30 M Decreased by -103.41% | Decreased by -0.12% Decreased by -103.21% |
| Dec 31, 21 | 1.10 B Decreased by -14.32% | 9.60 M Increased by +105.49% | Increased by +0.87% Increased by +106.40% |